These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37185957)

  • 21. Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management.
    Newman NJ; Yu-Wai-Man P; Biousse V; Carelli V
    Lancet Neurol; 2023 Feb; 22(2):172-188. PubMed ID: 36155660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inherited eye-related disorders due to mitochondrial dysfunction.
    Yu-Wai-Man P; Newman NJ
    Hum Mol Genet; 2017 Aug; 26(R1):R12-R20. PubMed ID: 28481993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.
    Horga A; Pitceathly RD; Blake JC; Woodward CE; Zapater P; Fratter C; Mudanohwo EE; Plant GT; Houlden H; Sweeney MG; Hanna MG; Reilly MM
    Brain; 2014 Dec; 137(Pt 12):3200-12. PubMed ID: 25281868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired mitochondrial impairment as a cause of optic nerve disease.
    Sadun A
    Trans Am Ophthalmol Soc; 1998; 96():881-923. PubMed ID: 10360310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition, investigation and management of mitochondrial disease.
    Davison JE; Rahman S
    Arch Dis Child; 2017 Nov; 102(11):1082-1090. PubMed ID: 28647693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mitochondrial diabetes: clinical features, diagnosis and management].
    Meas T; Laloi-Michelin M; Virally M; Ambonville C; Kevorkian JP; Guillausseau PJ
    Rev Med Interne; 2010 Mar; 31(3):216-21. PubMed ID: 19299044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Retinopathy.
    Birtel J; von Landenberg C; Gliem M; Gliem C; Reimann J; Kunz WS; Herrmann P; Betz C; Caswell R; Nesbitt V; Kornblum C; Charbel Issa P
    Ophthalmol Retina; 2022 Jan; 6(1):65-79. PubMed ID: 34257060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.
    Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA
    Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optic neuropathies in inherited metabolic disorders.
    Huizing M; Brooks BP; Anikster Y
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):97-103. PubMed ID: 16361983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial disease in children.
    Rahman S
    J Intern Med; 2020 Jun; 287(6):609-633. PubMed ID: 32176382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Impairment in Antibiotic Induced Toxic Optic Neuropathies.
    Yu JJ; Lee DH; Gallagher SP; Kenney MC; Boisvert CJ
    Curr Eye Res; 2018 Oct; 43(10):1199-1204. PubMed ID: 30040491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multisystem manifestations of mitochondrial disorders.
    Di Donato S
    J Neurol; 2009 May; 256(5):693-710. PubMed ID: 19252802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-related mitochondrial optic neuropathies.
    Wang MY; Sadun AA
    J Neuroophthalmol; 2013 Jun; 33(2):172-8. PubMed ID: 23681241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical syndromes associated with Coenzyme Q
    Alcázar-Fabra M; Trevisson E; Brea-Calvo G
    Essays Biochem; 2018 Jul; 62(3):377-398. PubMed ID: 30030365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management.
    Nesbitt V; Pitceathly RD; Turnbull DM; Taylor RW; Sweeney MG; Mudanohwo EE; Rahman S; Hanna MG; McFarland R
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):936-8. PubMed ID: 23355809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary optic neuropathies share a common mitochondrial coupling defect.
    Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
    Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial disorders with significant ophthalmic manifestations.
    Al-Enezi M; Al-Saleh H; Nasser M
    Middle East Afr J Ophthalmol; 2008 Apr; 15(2):81-6. PubMed ID: 21346843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and research progress on the treatment of mitochondrial optic neuropathy].
    Guo ST; Jiang LB
    Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):386-390. PubMed ID: 33915644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraneoplastic retinopathies and optic neuropathies.
    Chan JW
    Surv Ophthalmol; 2003; 48(1):12-38. PubMed ID: 12559325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapies in inborn errors of oxidative metabolism.
    Schiff M; Bénit P; Jacobs HT; Vockley J; Rustin P
    Trends Endocrinol Metab; 2012 Sep; 23(9):488-95. PubMed ID: 22633959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.